We are pleased that The International Africa AIDS Foundation has included NeedleZap® as part of their effort to focus on eliminating the re-use of contaminated needles as a way to help curtail the spread of HIV/AIDS on the African continent
Columbus, OH (PRWEB) December 29, 2004
E Med Future, Inc. (OTCBB: EMDF) has received a five million dollar ($5,000,000) purchase order for NeedleZapÂ®, a device that disintegrates used injection needles, from the International Africa AIDS Foundation, said Dane Donohue, Executive Vice President.
According to Donohue, Ray Bailey, Chairman of The International Africa AIDS Foundation, a private foundation, plans to distribute NeedleZapÂ® units throughout the 54 African countries during the first half of 2005. The terms of the purchase order require the Foundation to prepay for all NeedleZapÂ® units prior to shipment.
"We are pleased that The International Africa AIDS Foundation has included NeedleZapÂ® as part of their effort to focus on eliminating the re-use of contaminated needles as a way to help curtail the spread of HIV/AIDS on the African continent," said Donohue. A recent report released by the United Nations estimates that 25.4 million people in sub-Saharan Africa are infected with HIV, an increase of 1 million from the 2003 report.
NeedleZapÂ® is currently being used in hospitals and clinics in the African countries of Uganda and Ghana. In addition, dignitaries and Ambassadors from more than 20 African nations attended a formal introduction of NeedleZapÂ® in Washington, D.C. last month.
For more information about E Med Future or NeedleZapÂ®, call 877-855-1319 or visit http://www.needlezap.com.
Statements that describe E Med's future plans, objectives or goals are forward-looking statements. These forward-looking statements can generally be identified as such because the context of the statement will include words such as E Med "expects," "anticipates" or words of similar import. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of E Med, as appropriate, and market valuations of their stock, which could cause actual results to differ materially from those currently anticipated. Please refer to E Med's 10-K, 10-Qs and other filings with the SEC for a description of other factors that could cause actual results to differ from those anticipated.
E Med Future, Inc.
Don Sullivan, 877-855-1319
# # #